Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135)

Summary

Provide pre-approval single-patient Expanded Access (Compassionate Use) of elranatamab for patients with relapsed/refractory multiple myeloma

Timeline

Start

—

Primary completion

—

Completion

—

Drugs

Indications